| 标题 |
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hepatology 作者:Ciro Celsa; Giuseppe Cabibbo; Claudia Angela Maria Fulgenzi; Salvatore Battaglia; Marco Enea; et al 出版日期:2024-07-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)